Journal of Anaesthesiology Clinical Pharmacology (Jan 2021)

Novel management of critically induced polyneuropathy in intensive care patients: A case report of two patients

  • Vanita Ahuja,
  • Selwin Rajan Selvam,
  • Anjuman Chander,
  • Nishit Sawal

DOI
https://doi.org/10.4103/joacp.joacp_427_19
Journal volume & issue
Vol. 37, no. 2
pp. 290 – 292

Abstract

Read online

There has been tremendous growth in patients requiring critical care with severe infections. During a prolonged stay in the intensive care unit (ICU), patients develop critical illness polyneuropathy (CIP). The early identification of neurological involvement requires special attention during ICU care. We describe two cases who developed complete motor weakness after a prolonged stay in ICU. Patients were successfully managed with pyridostigmine and testosterone hormonal therapy initially and later with pyridostigmine only. The present case series highlights the need for early recognition, assessment, and novel management of CIP in ICU patients. However, the role of nutrition, physiotherapy, and supportive care is equally essential for the successful outcome in these patients.

Keywords